APA (7th ed.) Citation

Licaj, M., Mhaidly, R., Kieffer, Y., Croizer, H., Bonneau, C., Meng, A., . . . Mechta-Grigoriou, F. (2024). Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nature communications, 15(1), 1312-27. https://doi.org/10.1038/s41467-024-45595-3

Chicago Style (17th ed.) Citation

Licaj, Monika, et al. "Residual ANTXR1+ Myofibroblasts After Chemotherapy Inhibit Anti-tumor Immunity via YAP1 Signaling Pathway." Nature Communications 15, no. 1 (2024): 1312-27. https://doi.org/10.1038/s41467-024-45595-3.

MLA (9th ed.) Citation

Licaj, Monika, et al. "Residual ANTXR1+ Myofibroblasts After Chemotherapy Inhibit Anti-tumor Immunity via YAP1 Signaling Pathway." Nature Communications, vol. 15, no. 1, 2024, pp. 1312-27, https://doi.org/10.1038/s41467-024-45595-3.